Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4
Original Research
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,100 | Dovepress* | 11,769+ | 2,213 | 13,982 | |
| PubMed Central* | 2,331 | 715 | 3,046 | ||
| Totals | 14,100 | 2,928 | 17,028 | ||
|
*Since 26 January 2012 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar